-
2024-516651-41-00
5
2021-10-08
COPD : chronic obstructive Pulmonary disease
-
2024-514461-19-00
9
2021-09-09
Solid Tumors
-
2023-507132-21-00
10
2021-05-11
Early Parkinson's disease
-
2023-506899-27-00
5
2021-03-25
Relapsed or refractory diffuse large B-cell lymphoma
-
2024-512028-12-00
4
2021-03-19
Advanced ROS1-positive non-small cell lung cancer
-
2022-503072-84-00
5
2021-02-13
stage IIIa cardiac AL amyloidosis
-
2022-503073-11-00
5
2021-02-13
Stage IIIb cardiac AL amyloidosis
-
2024-513252-15-00
4
2021-01-28
IN RELAPSED/REFRACTORY PATIENTS WITH PERIPHERAL T-CELL LYMPHOMA
-
2024-515944-22-00
4
2021-01-19
BRAFV600E-mutant metastatic Non-small Cell Lung Cancer
-
2023-507263-19-00
5
2020-12-23
Advanced Non-Small Cell Lung Cancer
-
2024-514104-14-00
4
2020-11-04
Adults subjects with advanced malignant pleural (cohort A) or peritone
-
2024-511185-37-00
6
2020-11-03
Completely resected stage I or IIA non-squamous non-small cell lung
ca
-
2024-515331-30-00
7
2020-10-30
Primary Central Nervous System Lymphoma (PCNSL)
-
2024-516673-68-00
5
2020-10-27
Human papillomavirus (HPV)-positive oropharyngeal cancer
-
2024-516102-36-00
4
2020-07-29
Minimal Change Nephrotic Syndrom
-
2023-503628-22-00
5
2020-07-16
Lupus Nephritis (LN)
-
2024-512269-14-00
5
2020-01-27
GIant cell Arteritis
-
2024-511747-25-00
4
2019-12-23
B-cell non-Hodgkin lymphoma (NHL)
-
2024-518836-36-00
5
2019-10-07
Respiratory Distress Syndrome of preterm babies born < 32 weeks of ges
-
2023-506153-38-00
5
2019-07-11
High-risk localized or locally advanced prostate cancer
-
2024-516048-24-00
4
2019-06-19
CHRONIC MYELOGENOUS LEUKAEMIA IN ACCELERATED PHASE OR IN MYELOID BLAST
-
2024-512165-13-00
4
2019-05-13
Localised unresectable adenocarcinoma or squamous cell carcinoma of th
-
2023-507902-15-00
4
2019-03-26
Non-Small Cell Lung Cancer
-
2022-502832-37-00
5
2019-03-01
Acute myeloid leukemia